The biggest stories of the day delivered to your inbox.

Bayer’s oral FXIa inhibitor asundexian has significantly reduced the risk of stroke in a phase 3 trial, giving a boost to a potentially blockbuster mechanism that has suffered setbacks over the past ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A novel GLP-1 and amylin receptor agonist reduced HbA1c ...

With a phase 3 win for a combination of its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) and Keytruda, Merck & Co.’s partner Kelun-Biotech is the latest to claim that ...

Fans will be able to apply for single-match tickets based on exact match-ups and teams for group-stage games. High demand continues as the Early Ticket Draw sees inventory snatched up by fans in more ...

Johnson & Johnson’s attempt to develop a $5 billion-a-year Alzheimer’s disease drug has been rocked by a phase 2 flop. A scheduled data review found the anti-tau antibody posdinemab failed to ...

Turkish, Qatari and Egyptian officials met Wednesday in Cairo to discuss the second phase of the Israel-Hamas ceasefire deal. The meeting is said to have included Turkey and Egypt's intelligence ...

WASHINGTON, Nov 22 (Reuters) - The United States is poised to launch a new phase of Venezuela-related operations in the coming days, four U.S. officials told Reuters, as the Trump administration ...

Today, the Council presidency and the European Parliament’s representatives reached a provisional agreement on the regulation to phase out imports of Russian natural gas. The regulation constitutes a ...

KHAN YOUNIS, Gaza Strip (AP) — Israel handed over the bodies of 15 Palestinians on Wednesday, a day after Hamas returned the remains of an Israeli hostage. This is the latest swap as part of a ...